Cas:318951-60-9 5-(trifluoromethyl)-1H-pyrazole-4-carbonitrile manufacturer & supplier

We serve Chemical Name:5-(trifluoromethyl)-1H-pyrazole-4-carbonitrile CAS:318951-60-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

5-(trifluoromethyl)-1H-pyrazole-4-carbonitrile

Chemical Name:5-(trifluoromethyl)-1H-pyrazole-4-carbonitrile
CAS.NO:318951-60-9
Synonyms:HMS1366M09;3-(trifluoromethyl)-4-cyanopyrazole;3-(trifluoromethyl)-1H-pyrazole-4-carbonitrile
Molecular Formula:C5H2F3N3
Molecular Weight:161.08500
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:302.6ºC at 760 mmHg
Density:1.53g/cm3
Index of Refraction:1.447
PSA:52.47000
Exact Mass:161.02000
LogP:1.30018

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like HMS1366M09 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(trifluoromethyl)-1H-pyrazole-4-carbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,HMS1366M09 Use and application,HMS1366M09 technical grade,usp/ep/jp grade.


Related News: China considers self-ruled Taiwan to be part of its territory and has long sought to limit its diplomatic relations and recognition at international bodies such as the W.H.O. 5-(trifluoromethyl)-1H-pyrazole-4-carbonitrile manufacturer Health Canada said it was planning an onsite inspection this summer and that it would not accept any product or ingredients made at the plant until the inspection was complete. 5-(trifluoromethyl)-1H-pyrazole-4-carbonitrile supplier The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD. 5-(trifluoromethyl)-1H-pyrazole-4-carbonitrile vendor The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD. 5-(trifluoromethyl)-1H-pyrazole-4-carbonitrile factory The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD.